These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33148356)

  • 1. Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives.
    Wu J; Cao C; Loch RA; Tiiman A; Luo J
    Q Rev Biophys; 2020 Nov; 53():e12. PubMed ID: 33148356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Molecule Characterization of Amyloid Oligomers.
    Yang J; Perrett S; Wu S
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species.
    Ruggeri FS; Habchi J; Cerreta A; Dietler G
    Curr Pharm Des; 2016; 22(26):3950-70. PubMed ID: 27189600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids.
    Horrocks MH; Lee SF; Gandhi S; Magdalinou NK; Chen SW; Devine MJ; Tosatto L; Kjaergaard M; Beckwith JS; Zetterberg H; Iljina M; Cremades N; Dobson CM; Wood NW; Klenerman D
    ACS Chem Neurosci; 2016 Mar; 7(3):399-406. PubMed ID: 26800462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Single-Molecule Vibrational Spectroscopic Techniques for the Structural Investigation of Amyloid Oligomers.
    Vu KHP; Blankenburg GH; Lesser-Rojas L; Chou CF
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale Probing of Informational Polymers with Nanopores. Applications to Amyloidogenic Fragments, Peptides, and DNA-PNA Hybrids.
    Luchian T; Park Y; Asandei A; Schiopu I; Mereuta L; Apetrei A
    Acc Chem Res; 2019 Jan; 52(1):267-276. PubMed ID: 30605305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-molecule studies of protein folding.
    Borgia A; Williams PM; Clarke J
    Annu Rev Biochem; 2008; 77():101-25. PubMed ID: 18412537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
    Bhasne K; Mukhopadhyay S
    Proteomics; 2018 Nov; 18(21-22):e1800059. PubMed ID: 30216674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational opportunities for amyloid-targeting fluorophores.
    Cao KJ; Yang J
    Chem Commun (Camb); 2018 Aug; 54(66):9107-9118. PubMed ID: 29993065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins.
    Munishkina LA; Fink AL
    Biochim Biophys Acta; 2007 Aug; 1768(8):1862-85. PubMed ID: 17493579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring interactions between lipids and amyloid-forming proteins: A review on applying fluorescence and NMR techniques.
    Chang Z; Deng J; Zhao W; Yang J
    Chem Phys Lipids; 2021 May; 236():105062. PubMed ID: 33600803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
    Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
    Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
    Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
    Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
    Sengupta I; Udgaonkar JB
    Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
    Ilie IM; Caflisch A
    Chem Rev; 2019 Jun; 119(12):6956-6993. PubMed ID: 30973229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine and protein misfolding diseases.
    Kransnoslobodtsev AV; Shlyakhtenko LS; Ukraintsev E; Zaikova TO; Keana JF; Lyubchenko YL
    Nanomedicine; 2005 Dec; 1(4):300-5. PubMed ID: 16467913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Molecule FRET Detection of Early-Stage Conformations in α-Synuclein Aggregation.
    Moosa MM; Ferreon JC; Ferreon ACM
    Methods Mol Biol; 2019; 1948():221-233. PubMed ID: 30771181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.